Price Chart

Profile

Oncology Pharma Inc is engaged in the development, manufacturing, and commercialization of therapeutics. Its NanoSmart's platform technology is a human-derived, antinuclear antibody (ANA) that targets areas of necrosis present in solid tumors. The company is developing a novel drug delivery vehicle that targets many types of cancer.
URL https://www.oncology-pharma.com
Investor Relations URL N/A
HQ State/Province California
Sector Health Care
Industry Biotechnology
Equity Style Small Cap/Value
Next Earnings Release N/A
Last Earnings Release N/A
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Oncology Pharma Inc is engaged in the development, manufacturing, and commercialization of therapeutics. Its NanoSmart's platform technology is a human-derived, antinuclear antibody (ANA) that targets areas of necrosis present in solid tumors. The company is developing a novel drug delivery vehicle that targets many types of cancer.
URL https://www.oncology-pharma.com
Investor Relations URL N/A
HQ State/Province California
Sector Health Care
Industry Biotechnology
Equity Style Small Cap/Value
Next Earnings Release N/A
Last Earnings Release N/A
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A